Disclosure 0001614740-26-000014-1

SEC FORM 4

$101,802.95

Mirum Pharmaceuticals, Inc. (MIRM)

Acquisition (code M) of 5,305 shares at $19.19 per share.

Reporting Person Peetz Christopher · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code M

Traded Oct 6, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001614740-26-000014 · filed 2026-10-06 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Mirum Pharmaceuticals, Inc. (MIRM)." Disclosed 2026-10-06. https://desqlong.com/cards/0001614740-26-000014-1 (retrieved 2026-10-07).